⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28163117 | 0.97 | LMNA (0.32) | — | |
| SCHEMBL17629466 | 0.82 | — | — | |
| SCHEMBL11066259 | 0.79 | — | — | |
| SCHEMBL12682066 | 0.79 | — | — | |
| SCHEMBL8143838 | 0.79 | — | — | |
| SCHEMBL23153057 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL12492947 | 0.77 | MAPT (0.33) | — | |
| SCHEMBL3351302 | 0.77 | MAPT (0.33) | — | |
| SCHEMBL21662435 | 0.77 | — | — | |
| SCHEMBL17365002 | 0.77 | SLC7A5 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 639 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118530642-B | Waterproof agent for edge sealing of wooden floor, preparation and application | 北京盛大华源科技有限公司 | 2026-02-27 | — | — | CN | claimed |
| CN-118530642-A | Waterproof agent for edge sealing of wooden floor, preparation and application | 北京盛大华源科技有限公司 | 2024-08-23 | — | — | CN | claimed |
| CN-117958479-A | Electronic cigarette liquid and preparation method thereof, and electronic cigarette | 比亚迪精密制造有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117956915-A | Cooling element | 菲尔特隆纳开发私人有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-111542526-B | Condensed imidazole derivatives substituted with tertiary hydroxyl groups as PI 3K-gamma inhibitors | 因赛特公司 | 2024-01-09 | — | — | CN | claimed |
| CN-117158620-A | Flavor composition for electronic cigarette, electronic cigarette liquid and preparation method of flavor composition | 比亚迪精密制造有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-116490160-A | A mixture containing 1, 2-alkanediol | 西姆莱斯股份公司 | 2023-07-25 | — | — | CN | claimed |
| CN-113720937-B | Method for measuring content of cooling agent in electronic smoke sol | 深圳市真味生物科技有限公司 | 2023-06-27 | — | — | CN | claimed |
| WO-2023063269-A1 | NONAQUEOUS COMPOSITION FOR ORAL CAVITY | ライオン株式会社 | 2023-04-20 | — | — | WO | claimed |
| EP-3996506-A1 | FORMULATIONS FOR CONTROL AND REPELLENCY OF BITING ARTHROPODS | Bedoukian Research, Inc. (US) | 2022-05-18 | — | — | EP | claimed |
| CN-1409630-A | Sustainable-release formulations for treating CNS-mediated disorders | NPS PHARMA INC (US) | 2003-04-09 | — | — | CN | claimed |
| JP-2002538106-A | — | — | 2002-11-12 | — | — | JP | claimed |
| EP-1225888-A2 | SUSTAINED-RELEASE FORMULATIONS FOR TREATING CNS-MEDIATED DISORDERS | NPS PHARMACEUTICALS, INC. (US) | 2002-07-31 | — | — | EP | claimed |
| US-6383527-B1 | FOR TREATMENT OF ACUTE MUSCULAR ACHES, STRAINS, AND SPRAINS WHICH OCCUR FROM A LOCALIZED, EXTERNAL INSULT TO A PARTICULAR MUSCLE OR MUSCLE GROUP | NPS PHARMACEUTICALS, INC. | 2002-05-07 | — | — | US | claimed |
| WO-2002032884-A2 | METHODS FOR THE PREPARATION OF BIPHENYL ISOXAZOLE SULFONAMIDES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-04-25 | — | — | WO | claimed |
| EP-1176953-A2 | TREATMENT OF A VARIETY OF PATHOLOGICAL CONDITIONS, INCLUDING SPASTICITY AND CONVULSIONS, BY EFFECTING MODULATION OF CNS ACTIVITY WITH ISOVALERAMIDE, ISOVALERIC ACID, OR A RELATED COMPOUND | NPS PHARMACEUTICALS, INC. (US) | 2002-02-06 | — | — | EP | claimed |
| WO-2001028516-A2 | SUSTAINED-RELEASE FORMULATIONS FOR TREATING CNS-MEDIATED DISORDERS | NPS PHARMACEUTICALS, INC. (US) | 2001-04-26 | — | — | WO | claimed |
| EP-1059930-A1 | COMPOSITIONS COMPRISING VALERIAN EXTRACTS, ISOVALERIC ACID OR DERIVATIVES THEREOF WITH A NSAID | NPS PHARMACEUTICALS, INC. (US) | 2000-12-20 | — | — | EP | claimed |
| WO-2000051586-A2 | TREATING A VARIETY OF PATHOLOGICAL CONDITIONS, INCLUDING SPASTICITY AND CONVULSIONS, BY EFFECTING MODULATION OF CNS ACTIVITY WITH ISOVALERAMIDE, ISOVALERIC ACID, OR A RELATED COMPOUND | NPS PHARMACEUTICALS, INC. (US) | 2000-09-08 | — | — | WO | claimed |
| WO-1999044623-A1 | COMPOSITIONS COMPRISING VALERIAN EXTRACTS, ISOVALERIC ACID OR DERIVATIVES THEREOF WITH A NSAID | NPS PHARMACEUTICALS, INC. (US) | 1999-09-10 | — | — | WO | claimed |